European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment

• DOI: 10.1111/jdv.13957
• Publication Date: 2016-08-31T18:37:29Z
• Authors: R.N. Werner; A.F. Nikkels; B. Marinović; M. Schäfer; M. Czarnecka‐Operacz; A.M. Agius; Z. Bata‐Csörgő; J. Breuer; G. Girolomoni; G.E. Gross; S. Langan; R. Lapid‐Gortzak; T.H. Lesser; U. Pleyer; J. Sellner; G.M. Verjans; P. Wutzler; C. Dressler; R. Erdmann; S. Rosumeck; A. Nast
• Keywords: Guideline; Famciclovir; Interventional pain management; Venereology

Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life affected patients. Different therapeutic approaches to treat acute HZ are available. The aim this European project was elaboration consensus-based guideline on management patients who present with HZ, considering different patient populations and localizations. This interdisciplinary aims at an improvement outcomes concerning disease duration, pain reduction in incidence postherpetic neuralgia (PHN) other complications. development followed structured pre-defined process, criteria for guidelines as suggested by AGREE II instrument. steering group responsible planning organization process (Division Evidence-Based Medicine, dEBM). expert panel nominated virtue clinical expertise and/or scientific experience included experts from fields dermatology, virology/infectiology, ophthalmology, otolaryngology, neurology anaesthesiology. Recommendations practice were formally consented during consensus conference, explicitly relevant aspects. approved commissioning societies after extensive internal external review process. In second part guideline, interventions have been evaluated. recommendations treatment (antiviral medication, management, local therapy), various situations. Users must carefully check whether appropriate context intended application. setting international it generally important consider national legal circumstances regard regulatory approval, availability reimbursement diagnostic interventions.